Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Trial of Radical Chemo/Radiotherapy vs Radiotherapy Alone in the Definitive Management of Localised Muscle Invasive TCC of the Urinary Bladder

NCT00330499 is registered in ClinicalTrials.gov with Trans Tasman Radiation Oncology Group as lead sponsor.

NCT NCT00330499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00330499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Trial of Radical Chemo/Radiotherapy vs Radiotherapy Alone in the Definitive Management of Localised Muscle Invasive TCC of the Urinary Bladder
Lead sponsor
Trans Tasman Radiation Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2002
Completion date
February 28, 2010
Enrollment
67 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

transitional cell carcinoma of urinary bladder